People

Ian Aronson
Ian D. Aronson, PhD
NDRI-USA - Senior Scientist
NDRI-USA - Founding Director, Center for Technology-based Education and Community Health
Email: aronson@ndri-usa.org
Education
PhD, Educational Communication and Technology, New York University
MA, Documentary Film and Video, Stanford University
BA, English, State University of New York at Buffalo
Research Interests
Technology-based interventions, learning, behavior, video, clinical interventions, mobile
BIO
Ian David Aronson researches how technology-based interventions can most effectively be used to reach underserved populations in clinical and community settings. His NIH-funded projects include efforts to increase HIV testing and facilitate improved risk reporting in high volume emergency departments. He conducts his research in community settings to increase HIV/HCV testing, overdose prevention, and general access to healthcare among people who inject drugs. Dr. Aronson is the co-founder and Director of Research at Digital Health Empowerment.
Projects
Principal Investigator, Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Among People Who Inject Drugs. Active
Principal Investigator, Increasing HIV Testing and Re-testing among Emerging Adult ED Patients via Mobile Technology. Completed
Principal Investigator, Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology. Completed
Principal Investigator, Integrating Qualitative Methods to Inform Future Designs and Create a Replicable Mixed-Methods Model of Evaluating Technology-Based Health Interventions. Completed
Principal Investigator, Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care. Completed
Principal Investigator, Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care – Phase 2. Completed
Principal Investigator, Mobile Intervention Kit to Increase HIV/HCV Testing and Overdose Prevention Training. Completed
Principal Investigator, Mobile Intervention Kit to Increase HIV/HCV Testing and Overdose Prevention Training, Pre-Phase II Pilot. Completed
Principal Investigator, Optimizing Computer-Based Video to Increase HIV Testing in Emergency Departments. Completed
Principal Investigator, Technology to Increase Naloxone Uptake Among Opioid Users Who Initially Decline. Completed
Publications

Recent

Ibitoye M, Bennett AS, Des Jarlais DC, Bugaighis M, Chernick LS, Aronson ID (2024).
“I didn’t know what they’re gonna do to me: So that’s why I said no”: Why youth decline HIV testing in emergency departments
Behavioral Medicine, 50 (2), 47-54. doi: 10.1080/08964289.2022.2100864. PMCID: PMC9884312.

Ibitoye M, Bennett AS, Bugaghis M, Chernick LS, Des Jarlais DC, Aronson ID (2023).
Provider perspectives on barriers to routine HIV testing of adolescent and young adult patients in emergency department settings
Behavioral Medicine, 49 (2), 204-211. doi: 10.1080/08964289.2021.2020207. PMCID: PMC9240108.

Aronson ID, Bennett AS, Ardouin-Guerrier MA, Rivera-Castellar GJ, Gibson BE, Vargas-Estrella B (2022).
Using the participatory education and research into lived experience (PEARLE) methodology to localize content and target specific populations
Frontiers in Digital Health, 4, 992519. doi: 10.3389/fdgth.2022.992519. PMCID: PMC9634163.

Aronson ID, Zhang J, Rajan S, Marsch LA, Bugaighis M, Ibitoye MO, Chernick LS, Des Jarlais DC (2022).
Automated substance use/sexual risk reporting and HIV test acceptance among emergency department patients aged 13-24 years
AIDS and Behavior, 26 (5), 1544-1551. doi: 10.1007/s10461-021-03507-2. PMCID: PMC9007819.

Aronson ID, Bennett AS, Ardouin-Guerrier MA, Rivera-Castellar G, Gibson B, Santoscoy S, Vargas-Estrella B (2022).
How vaccine ambivalence can lead people who inject drugs to decline COVID-19 vaccination, and ways this can be addressed: A qualitative study
JMIR Formative Research, 6 (3), e35066. doi: 10.2196/35066. PMCID: PMC8945077.

Dr. Aronson's Google Scholar Profile